0
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Screening of Concentrations of C-reactive Protein and Various Plasma Protease Inhibitors Preoperatively for the Prediction of Postoperative Complications

, &
Pages 89-101 | Received 01 Sep 2001, Published online: 04 Dec 2011

REFERENCES

  • Ades EW, Hinson A, Chapuis-Cellier C, Arnaud P. Modulation of the immune response by plasma protease inhibitors. Scand J Immunol 1982; 15: 109–113.
  • Ballmer PE, Ochsenbein AF, Schutz-Hofmann S. Trans-capillary escape rate of albumin positively correlates with plasma albumin concentration in acute but not in chronic inflammatory disease. Metabolism 1994; 43: 697–705.
  • Ballou SP, Kushner I. C-reactive protein and the acute phase response. Adv Intern Med 1992; 37: 313–336.
  • Berling R, Lasson A, Axelsson L, Hjelmqvist B, Ohlsson K. Plasma CRP levels in the prediction of complications during acute pancreatitis. Surg Res Commun 1990; 8: 241–249.
  • Borth W. Alpha-2-macroglobulin. A multifunctional binding and targeting protein with possible roles in immunity and autoimmunity. Ann NY Acad Sci 1994; 737: 267–272.
  • Buehler M, Malfertheiner P. Uhl W, Beger HG. C-reactive protein as a marker of inflammation and necrosis in gastroenterology (C-reaktives Protein als Entziindungs- und Nekrosemarker in der Gastroenter-ologie). Med Klin 1987; 82: 180–185.
  • Miller HR, Bolwerk C, ten Cate J, Roos J, Kahl6 LH, ten Cate JVV. Postoperative hemostatic profile in relation to Gram negative septicemia. Crit Care Med 1982; 10: 311–315.
  • Cafiero F, Gipponi M, Bonalumi U, Piccardo A, Sguotti C, Corbetta G. Prophylaxis of infection with intravenous immunoglobulins plus antibiotic for patients at risk for sepsis undergoing surgery for colorectal cancer: Results of a randomized, multicenter clinical trial. Surgery 1992; 112: 24–31.
  • Cafiero F, Gipponi M, Moresco L, Capuzzo R, Mansuino P, Di Giorgio F, Verganelli E. Selection of pre-operative haematobiochemical parameters for the identification of patients "at risk of infection" under-going surgery for gastro-intestinal cancer. Eur J Surg Oncol 1989; 15: 247–252.
  • Christou NV, Tellado-Rodriguez J, Chartrand L, et al. Estimating mortality risk in preoperative patients using immunologic, nutritional, and acute-phase response variables. Ann Surg 1989; 210: 69–77.
  • Chu CT, Howard GC, Misra UK, Pizzo SV. Alpha-2-macroglobulin: a sensor for proteolysis. Ann NY Acad Sci 1994; 737: 291–307.
  • Civetta JM, Hudson-Civetta JA, Nelson LD. Evaluation of APACHE II for cost containment and quality assurance. Ann Surg 1990; 212: 266–276.
  • Cruickshank AM, Hansell DT, Bums MJG, Shenkin A. Effect of nutritional status on acute phase protein response to elective surgery. Br J Surg 1989; 76: 165–168.
  • Dinarello CA. Role of interleukin-1 in infectious diseases. Immunol Rev 1992; 127: 119–146.
  • Donnelly PK, Shenton BK, Alomran AM, Francis DMA, Proud G, Taylor RMR. The role of protease in immuno-regulation. Br J Surg 1983; 70: 614–622.
  • Doyle HR, Marino IR, Jabbour N, et al. Early death or retransplantation in adults after orthotopic liver trans-plantation. Transplantation 1994; 57: 1028–1036.
  • Fischer CL, Gill C, Forrester MG, Nakamura R. Quan-titation of "acute-phase proteins" postoperatively. Am J Clin Pathol 1976; 66: 840–846.
  • Friberger P. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems. Scand J Clin Lab Invest 1982; 42\(suppl 162): 84–89.
  • Gagner M. Value of preoperative physiologic assess-ment in outcome of patients undergoing major surgical procedures. Surg Clin North Am 1991; 71: 1141–1150.
  • Ganrot PO. Crossed immunoelectrophoresis. Scand J Clin Lab Invest 1972; 29\(suppl 124): 39–47.
  • Goodson WH, Lopez-Sarmiento A, Jensen JA, West J, Granja-Mena L, Chavez-Estrella J. The influence of a brief preoperative illness on postoperative healing. Ann Surg 1987; 205: 250–255.
  • Göransson J, Lasson A. Plasma levels of C-reactive protein in the diagnosis of acute abdominal disease. Surg Res Commun 1991; 11: 107–118.
  • Gosling P, Dickson GR. Serum C-reactive protein in patients with serious trauma. Injury 1992; 23: 483–486.
  • Hack CE, Ogilvie AC, Eisele B, Eerenberg AJM, Wagstaff J, Thijs LG. Cl-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2. Int Care Med 1993; 19: 19–28.
  • Hames BD, Richwood D, eds. Gel electrophoresis of proteins. A practical approach. London: IRL Press Ltd., 1987.
  • Hedner U, Martinsson G, Bergqvist D. Influence of operative trauma on factor XII and inhibitor of plasminogen activator. Haemostasis 1983; 13: 219–226.
  • Hörl M, Sperling M, Mayer J, Hörl WH. Plasma proteinases, proteinase inhibitors and other selective plasma proteins following aortofemoral bypass opera-tion. Eur Surg Res 1986; 18: 69–79.
  • Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II-A severity of disease classification system. Crit Care Med 1985; 13: 818–829.
  • Kress HG, Gehrsitz P. Elert 0. Predictive value of skin testing, neutrophil migration and C-reactive protein for postoperative infections in cardiopulmonary bypass patients. Acta Anaesthesiol Scand 1987; 31: 397–404.
  • Kreuzer E, Kääb S, Pilz G, Werdan K. Early prediction of septic complications after cardiac surgery by APACHE II score. Eur J Cardiothorac Surg 1992; 6: 524–529.
  • Lämmle B, Tran TH, Ritz R, Duckert F. Plasma kallikrein, factor XII, antithrombin III, Cl-inhibitor and alpha-2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am J Clin Pathol 1984; 82: 396–404.
  • Lasson A, Berling R, Göransson J. Plasma CRP-levels in the diagnosis of postoperative complications. Surg Res Commun 1992; 12: 203–211.
  • Lasson A, Berling R, Göransson J, Ohlsson K. Alpha-2-macroglobulin decreases parallel to albumin and hemo- globin after elective surgery. Scand J Clin Lab Invest 1991; 51.: 225–233.
  • Lasson A, Delshammar M, Ohlsson K. Severity scoring and prediction of complications in peritonitis. Surg Res Commun 1988; 3: 327–334.
  • Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29\(suppl 124): 21–37.
  • Lennard TWJ, Shenton BK, Borzotta A, et al. The influence of surgical operations on components of the human immune system. Br J Surg 1985; 72: 771–776.
  • Lindmark G, Gerdin B, Pdhlman L, Bergstrom R, Glimelius B. Prognostic predictors in colorectal cancer. Dis Colon Rectum 1994; 37: 1219–1227.
  • Meakins JL. Host defense mechanisms in surgical patients: effect of surgery and trauma. Acta Chir Scand 1989; 550: 43–53.
  • Miholic J, Hudec M, Muller MM, Domanig E, Wolner E. Early prediction of deep sternal wound infection after heart operations by alpha-1 acid glycoprotein and C-reactive protein measurements. Ann Thome Surg 1986; 42: 429–433.
  • Mustard RA, Bohnen JMA, Haseeb S, Kasina R. C-reactive protein levels predict postoperative septic complications. Arch Surg 1987; 122: 69–73.
  • Mythen MG, Purdy G, Mackie IJ, McNally T, Webb AR, Machin SJ. Postoperative multiple organ dysfunc-tion syndrome associated with gut mucosal hypoperfu-sion, increased neutrophil degranulation and Cl-esterase inhibitor depletion. Br J Anaesth 1993; 71: 858–863.
  • Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, Gotoh M, Kishimoto T, Mori T. Interleukin-6 as a new indicator of inflammatory status: Detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992; 111: 201–209.
  • Pepys MB, Baltz ML. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983; 34: 141–211.
  • Pettigrew RA, Charlesworth PM, Farmilo RW, Hill GL. Assessment of nutritional depletion and immune com-petence: A comparison of clinical examination and objective measurements. JPEN 1983; 8: 21–24.
  • Raynes JG, Cooper EH. Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. J Clin Pathol 1983; 36: 798–803.
  • Schentag JJ, O'Keeffe D, Marmion M, WeIs PB. C-reactive protein as an indicator of infection relapse in patients with abdominal sepsis. Arch Surg 1984; 119: 300–304.
  • Shakespeare PG, Ball AJ, Spurr ED. Serum protein changes after abdominal surgery. Ann Clin Biochem 1989; 26: 49–57.
  • Snedecor GW, Cochran WG, eds. Statistical methods. 7th ed. Ames: Iowa State University Press 1982.
  • Stahl WM. Acute phase protein response to tissue injury. Crit Care Med 1987; 15: 545–550.
  • Tellado-Rodriguez J, Christou NV. Clinical assessment of host defense. Surg Clin North Am 1988; 68: 41–55.
  • Tsujimoto M, Inoue K, Nojima S. Purification and characterization of human serum C-reactive protein. J Biochem 1983; 94: 1367–1373.
  • Velanovich V. Preoperative laboratory screening based on age, gender, and concomitant medical diseases. Surgery 1994; 115: 56–61.
  • Velanovich V. The value of routine preoperative laboratory testing in predicting postoperative complica-tions: A multivariate analysis. Surgery 1991; 109: 236–243.
  • Veterans Affairs Total Parenteral Nutritional Coopera-tive Study Group. Perioperative total parenteral nutrition in surgical patients. N Engl J Med 1991; 325: 525–532.
  • Wachtfogel YT, De La Cadena RA, Colman RW. Structural biology, cellular interactions and pathophy-siology of the contact system. Thromb Res 1993; 72: 1–21.
  • Waydhas C, Nast-Kolb D, Kick M, et al. Operation planning of secondary interventions after polytrauma (Operationsplanung von sekundären Eingriffen nach Polytrauma). Unfallschirurg 1994; 97: 244–249.
  • Waydhas C, Nast-Kolb D, Jochum M, et al. Inflamma-tory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg 1992; 127: 460–467.
  • Wortel CH, van Deventer JH, Aarden LA, et al. Interleukin-6-mediates host defense responses induced by abdominal surgery. Surgery 1993; 114: 564–570.
  • Wiist HJ, Fiedler HW, Trobisch H, Richter 0. Fibrinolysis and complement-system profiles during aorto-femoral bypass implantation (Fibrinolyse- und Komplementsystem-Profile während aortofemoraler Bypassimplantation). Anaesthesist 1982; 31: 564–574.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.